International Journal of Pharmaceutical Investigation, 2019, 9, 1, 1.
Published: March 2019
Managing Editor, International Journal of Pharmaceutical Investigation, #9, Vinnse Towers, Wheeler Road Extension, St. Thomas Town, Bangalore, INDIA
The year 2019 is another milestone for International Journal of Pharmaceutical Investigation (JPHI) as it is entering to 9th year. It is known as one of the peer-reviewed pharmaceutical journal and I am pleased to present you this issue being published by EManuscript, Bangalore, India. JPHI is publishing scholarly reviews and research articles in the field of pharmacy and bioallied Sciences. Over the years the journal is indexed with Emerging Sources Citation Index, Web of Science and Index Copernicus. The past and current issue content is available in http://jpionline.phcog.interactivedns.com/index.php/ijpi/issue/archive.
JPHI Publication Ethics and Publication Malpractice Statement are based, in large part, on the guidelines and standards developed by the Committee on Publication Ethics (COPE). Manuscripts being submitted to JPHI will be preferred in IMRAD style and its mandatory to provide contributors details and author have to declare the conflict of interest. The clinical and pre-clinical experiment should be prepared accordance to “CONSORT” and “ARIVE” guidelines respectively. The manuscripts which are describing clinical findings have to provide “CONSORT” flow chart.
The manuscript published by JPHI is an open access article distributed under the terms of the Creative Commons Attribution: Noncommercial- Share Alike 4.0 License, which allows others to remix, tweak and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. Read more. . .